• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Amyotrophic Lateral Sclerosis  • Neuromuscular diseases  • Neuropathology  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Sanjay Kalra, MD; Christopher C. Hanstock, PhD; W. R. Wayne Martin, MD; Peter S. Allen, PhD; Wendy S. Johnston, MD

Arch Neurol. 2006;63:1144-1148.

Background  Clinical assessment is insensitive to the degree of cerebral involvement in amyotrophic lateral sclerosis (ALS). Regional brain concentrations N-acetylaspartylglutamate (NAA) plus myo-inositol (Ins), as measured by magnetic resonance spectroscopy, are respectively decreased and increased, suggesting that these compounds may provide a biomarker of the degree of cerebral involvement in ALS.

Objective  To test the hypothesis that the NAA/Ins ratio may provide an index of cerebral involvement in patients with ALS.

Design  High-field (3.0-T) magnetic resonance spectroscopy was performed to determine the NAA/creatine plus phosphocreatine (NAA/Cr), NAA/choline (NAA/Cho), Ins/Cr, and NAA/Ins ratios in the motor cortex.

Participants  Seventeen patients with ALS and 15 healthy control subjects were studied.

Results  In patients with ALS, the greatest abnormality was a 22% decrease in NAA/Ins (71% sensitivity and 93% specificity, P = .001); Ins/Cr was increased 18% (88% sensitivity and 53% specificity, P = .04), NAA/Cr was decreased 10% (88% sensitivity and 47% specificity, P = .04), and NAA/Cho was decreased 14% (53% sensitivity and 87% specificity, P = .047). Correlation of the ALS Functional Rating Scale with NAA/Ins approached statistical significance (R = 0.43, P = .07).

Conclusion  The NAA/Ins ratio may provide a meaningful biomarker in ALS given its optimal sensitivity and specificity profile.

Author Affiliations: Division of Neurology, Department of Medicine (Drs Kalra, Martin, and Johnston), and Department of Biomedical Engineering (Drs Hanstock and Allen), University of Alberta, Edmonton.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS
Carew et al.
Neurology 2011;77:1370-1375.
ABSTRACT | FULL TEXT  

Mesial Prefrontal Cortex Degeneration in Amyotrophic Lateral Sclerosis: A High-Field Proton MR Spectroscopy Study
Usman et al.
Am. J. Neuroradiol. 2011;32:1677-1680.
ABSTRACT | FULL TEXT  

Degeneration of the Mid-Cingulate Cortex in Amyotrophic Lateral Sclerosis Detected In Vivo with MR Spectroscopy
Sudharshan et al.
Am. J. Neuroradiol. 2011;32:403-407.
ABSTRACT | FULL TEXT  

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis
Agosta et al.
Am. J. Neuroradiol. 2010;31:1769-1777.
ABSTRACT | FULL TEXT  

MR Spectroscopy Findings in Early Stages of Motor Neuron Disease
van der Graaff et al.
Am. J. Neuroradiol. 2010;31:1799-1806.
ABSTRACT | FULL TEXT